Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Nov 15, 2022--
The NGS)+Tests+Pipeline+Report+including+Stages+of+Development%2c+Segments%2c+Region+and+Countries%2c+Regulatory+Path+and+Key+Companies%2c+2022+Update&utm_exec=como322prd" rel="nofollow" shape="rect">"Next Generation Sequencing (NGS) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.
The publisher's Medical Devices sector report, "Next Generation Sequencing (NGS) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update' provides comprehensive information about the Next Generation Sequencing (NGS) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Next generation sequencing (NGS) refers to high-throughput methods for DNA sequencing that are not Sanger-based.
Scope
Reasons to Buy
The report enables you to:
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Next Generation Sequencing (NGS) Tests Overview
3 Products under Development
3.1 Next Generation Sequencing (NGS) Tests - Pipeline Products by Stage of Development
3.2 Next Generation Sequencing (NGS) Tests - Pipeline Products by Territory
3.3 Next Generation Sequencing (NGS) Tests - Pipeline Products by Regulatory Path
3.4 Next Generation Sequencing (NGS) Tests - Pipeline Products by Estimated Approval Date
3.5 Next Generation Sequencing (NGS) Tests - Ongoing Clinical Trials
4 Next Generation Sequencing (NGS) Tests - Pipeline Products under Development by Companies
4.1 Next Generation Sequencing (NGS) Tests Companies - Pipeline Products by Stage of Development
4.2 Next Generation Sequencing (NGS) Tests - Pipeline Products by Stage of Development
5 Next Generation Sequencing (NGS) Tests Companies and Product Overview
6 Appendix
6.1 Methodology
6.2 About the Publisher
6.3 Contact the Publisher
6.4 Disclaimer
Companies Mentioned
For more information about this report visit NGS)+Tests+Pipeline+Report+including+Stages+of+Development%2c+Segments%2c+Region+and+Countries%2c+Regulatory+Path+and+Key+Companies%2c+2022+Update&utm_exec=como322prd" rel="nofollow" shape="rect">https://www.researchandmarkets.com/r/kwwt24
View source version on businesswire.com:https://www.businesswire.com/news/home/20221115006027/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH GENETICS
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/15/2022 08:59 AM/DISC: 11/15/2022 08:59 AM
http://www.businesswire.com/news/home/20221115006027/en